Literature DB >> 11950913

Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.

Suzuko Moritani1, Ryoji Kushima, Hiroyuki Sugihara, Masamichi Bamba, Tadao K Kobayashi, Takanori Hattori.   

Abstract

CD10, also called common acute lymphoblastic leukemia antigen (CALLA), was recently found to be expressed in nonhematopoietic tissues. Although CD10 was also identified in human breast myoepithelial cells, its availability of immunohistochemistry on paraffin sections has not been examined so far. In the present study, we demonstrated CD10 immunohistochemically on paraffin sections of both normal and pathological breast tissues, comparing its staining patterns to those of smooth muscle actin (SMA), which is now commonly used to highlight myoepithelium. CD10 was consistently positive in normal breast myoepithelial cells. CD10 also clearly highlighted myoepithelial cells in intraductal papilloma, adenosis, ductal hyperplasia, fibroadenoma, and phyllodes tumor as well as SMA did. In atypical ductal hyperplasia and ductal carcinoma in situ, continuous, discontinuous, and totally negative stainings of both CD10 and SMA were noted, depending on foci of neoplastic cell nests. However, both stainings clearly demonstrated myoepithelial cells of cancerized acini, being useful in differentiating lobular cancerization from microinvasion. Because SMA was also positive in normal vessels and spindle-shaped stromal cells, CD10, which was negative in vessels, was useful in differentiating myoepithelial cells from thin vascular wall in intracystic lesions with delicate papillae. Although background staining of spindle-shaped stromal cells was also noted in CD10, the positive cell number was less, and the signal was weaker than that of SMA. The absence of myoepithelial cells in invasive ductal carcinomas was more clearly highlighted by CD10 than SMA. We concluded that CD10 could be another useful marker of breast myoepithelial cells on paraffin sections. Combination of CD10 and SMA will provide more sophisticated information about presence or absence of myoepithelial cells in confusing breast lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950913     DOI: 10.1038/modpathol.3880536

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  28 in total

1.  CD10 positivity in breast epithelial neoplasms.

Authors:  Amanpreet S Bains; Jagmohan S Sidhu
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

2.  Multiplex PCR analysis of apocrine lesions shows frequent PI3K-AKT pathway mutations in both benign and malignant apocrine breast tumors.

Authors:  Naoki Kanomata; Rin Yamaguchi; Junichi Kurebayashi; Takuya Moriya
Journal:  Med Mol Morphol       Date:  2019-05-28       Impact factor: 2.309

3.  Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.

Authors:  Werner Boecker; Göran Stenman; Thomas Loening; Mattias K Andersson; Tobias Berg; Alina Lange; Agnes Bankfalvi; Vera Samoilova; Katharina Tiemann; Igor Buchwalow
Journal:  Virchows Arch       Date:  2014-10-26       Impact factor: 4.064

4.  Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.

Authors:  Suzuko Moritani; Shu Ichihara; Ryoji Kushima; Hidetoshi Okabe; Masamichi Bamba; Tadao K Kobayashi; Takanori Hattori
Journal:  Virchows Arch       Date:  2007-03-22       Impact factor: 4.064

5.  Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast?

Authors:  Alfredo Ribeiro-Silva; Leandra N Zamzelli Ramalho; Sérgio Britto Garcia; Sérgio Zucoloto
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

6.  The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Authors:  G M K Tse; P-H Tan; P C W Lui; C B Gilks; C S P Poon; T K F Ma; B K B Law; W W M Lam
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

7.  Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.

Authors:  G M K Tse; A K H Tsang; T C Putti; R A Scolyer; P C W Lui; B K B Law; R Z Karim; C S Lee
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

8.  D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.

Authors:  Shuyue Ren; Mohammed Abuel-Haija; Jasvir S Khurana; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

9.  Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins.

Authors:  Suzuko Moritani; Shu Ichihara; Yasushi Yatabe; Masaki Hasegawa; Akari Iwakoshi; Waki Hosoda; Michihiko Narita; Yuichiro Nagai; Masami Asai; Nobuko Ujihira; Yoshiaki Yuba; Mayumi Jijiwa
Journal:  Virchows Arch       Date:  2014-12-06       Impact factor: 4.064

10.  Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity.

Authors:  A Skalova; A Cardesa; I Leivo; M Pfaltz; A Ryska; R Simpson; M Michal
Journal:  Virchows Arch       Date:  2003-06-25       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.